Pathology and Molecular Evolution of HTLV in Asia
Pathology and Molecular Evolution of HTLV in Asia
批准号:
07042008
负责人:
OSAME Mitsuhiro
金额:
$10.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997
中文摘要
本研究的目的是阐明亚洲HTLV/STLV感染的分子流行病学研究,并分析其与HLA的致病关系。1)在印度尼西亚新发现的3只猩猩和1只长颈鹿的STLV-I阳性病例。遗传分析表明,猩猩STLV-I变异较大,在遗传树中形成两个聚类。HTLV-I的美拉尼西亚群不太可能直接来自猩猩,尽管该群属于亚洲的大STLV-I群。2)在印度(Kelara的400名献血者,卡纳塔克邦的20名HAM/TSP患者)、马来西亚(北方吉兰丹的50名献血者)、泰国(泰国南部Songkhula的20名T淋巴瘤患者)和印度尼西亚(Iryanese,Inryan Jaya的220名患者)进行了HTLV-I的血清筛查。HTLV不是地方性的,没有测试的种族群体。3)为了研究HTLV分离株之间的分子系统发育关系,从印度Andra Pradesh的血清阳性受试者的淋巴细胞中提取基因组DNA,并用作PCR研究中的模板。在安得拉邦的两个独立的家庭中检测到前病毒基因组。在IL-2存在下培养淋巴细胞。培养6个月后,表达HTLV特异性抗原的细胞显示增殖。4)对来自巴基斯坦和阿富汗的200份标本(包括山区少数民族)、阿塞拜疆的900份标本和阿尔泰的900份标本进行了HTLV-I筛查,结果均为阴性。5)Mashhadi犹太人HAM/TSP患者的HLA分型显示B52型的高流行率,支持该类型与HTLV-I发病的重要关系。
英文摘要
The purpose of this resesrch is to clarify the HTLV/STLV infection in Asia and we conducted the molecular epidemiological search and analyzed pathogenic relations of HLA.1) STLV-I positive cases were newly detected on 3 orangutans and 1 gibbon in Indonesia. Genetic analysis showed STLV-I of orangutan was quite variable and made two clusters in phylogenetictree. It is not likely that Melanesian group of HTLV-I directly came from orangutan although the group belongs to big Asian STLV-I group. 2) Seroscreening for HTLV-I was carried out in India (400 blood donors in Kelara, 20 HAM/TSP patients in karnataka), Malaysia (50 donors in Kelantan, Northern Malaysia) , Thailand (20 T-lymphoma patients in Songkhula, Southern Thailand) and Indonesia (220 Iryanese, Inryan Jaya). HTLV was not endemic among none of the ethnic groups tested. 3) In order to study molecular phylogenetic relationships among the HTLV isolates, genomic DNAs were extracted from lymphocytes of seropositive subjects in India, Andra Pradesh, and used as templates in PCR studies. provirus genome was detected in two independent families in Andra Pradesh. The lymphocytes were cultured in the presence of IL-2. After six months in culture, cells expressing HTLV specific antigens showed proliferation. 4) About 200 samples from Pakistan and Afghanistan including minority of mountain area, about 900 samples from Azerbaijan, and about 900 samples from Altai were screened and resulted in all negative for HTLV-I.5) HLA typing of HAM/TSP patients from Mashhadi Jews showed high prevalence of B52 type, supporting the important relations of the tupe to HTLV-I pathogenesis.
期刊论文(38)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
M. Saito: "Mutation Rates in LTR of HTLV-I in HAM/TSP patients and the carriers are similarly high to Tax/Rex-coding sequence" Journal of Neuro Virology. 2. 330-335 (1996)
M. Saito:“HAM/TSP 患者和携带者中 HTLV-I LTR 的突变率与 Tax/Rex 编码序列的突变率相似”《神经病毒学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
G. Picchio: "HTLV-I/II Indeterminate Sevology and Natural Killer Cell Expansion" Journal of AIDS and Human Retro virology. 12. 428-431 (1996)
G. Picchio:“HTLV-I/II 不确定信号学和自然杀伤细胞扩增”艾滋病和人类逆转录病毒学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Gurtsevitch,V.,Hayami,M.,et al.: "HTLV-1 infection among Nivkhi people in Sakhalin." Int.J.Cancer. 60. 432-433 (1995)
Gurtsevitch,V.,Hayami,M.,et al.:“萨哈林岛尼夫赫人中的 HTLV-1 感染。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Ibuki, K., et al: "Isolation of STLV-I from orangutan, a great ape species in southeast Asia, and its relation to other HTLV-Is/STLV-Is" Jpn J Cancer Res. 88. 1-4 (1997)
Ibuki, K. 等人:“从东南亚的一种类人猿猩猩中分离出 STLV-I,及其与其他 HTLV-Is/STLV-Is 的关系”Jpn J Cancer Res。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
E. Ido: "Ethnic Variation of HTLV-I in the world" Gann Monograph on Cancer Research. 44. 107-120 (1996)
E. Ido:“世界 HTLV-I 的种族变异”江恩癌症研究专着。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 37 条
Exploitation of new therapies for HTLV-I-assotiated myelopathy
-
批准号:14207031
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$23.71万
-
财政年份:2002
-
负责人:OSAME Mitsuhiro
-
依托单位:
HAMの臨床病態・発症機序の解明並びに新治療法の開発に関する研究
-
批准号:11470146
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.15万
-
财政年份:1999
-
负责人:OSAME Mitsuhiro
-
依托单位:
Research on Pathomechanism and a novel treatment of HTLV-I-associated myelopathy (HAM)
-
批准号:09470155
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.26万
-
财政年份:1997
-
负责人:OSAME Mitsuhiro
-
依托单位:
Epidemiology and pathology of human retrovirus infection
-
批准号:06042013
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$3.26万
-
财政年份:1994
-
负责人:OSAME Mitsuhiro
-
依托单位:
Epidemiology and pathology of human retro virus infection.
-
批准号:04042017
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$7.3万
-
财政年份:1992
-
负责人:OSAME Mitsuhiro
-
依托单位:
RESEARCH FOR THE PATHOMECHANISM, EPIDEMILOGY AND TREATMENTS FOR HAM AND HTLV-I RELATED DISORDERS.
-
批准号:03454219
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.97万
-
财政年份:1991
-
负责人:OSAME Mitsuhiro
-
依托单位:
Research of Clinical Features and Pathomechanism of HAM
-
批准号:62480208
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.22万
-
财政年份:1987
-
负责人:OSAME Mitsuhiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
pH响应型靶向ATL@Fe-MOF@M纳米载体在胆囊癌双模式成像指导下光热/化学动力协同免疫治疗的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:
-
依托单位:
遗传性感觉神经病中ATL3突变致轴索末梢内质网功能障碍的机制研究
-
批准号:LZ23H090004
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:赵国华
-
依托单位:
拟南芥E3泛素连接酶ATL5调控种子寿命的作用机制研究
-
批准号:32070349
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:陈喜文
-
依托单位:
拟南芥E3泛素连接酶ATL17调控脱落酸抑制主根生长的分子机制研究
-
批准号:31870248
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:郝福顺
-
依托单位: